LetterLetter
Anakinra for the Treatment of Antisynthetase Syndrome: A Monocentric Case Series and a Systematic Literature Review
Corrado Campochiaro, Nicola Farina, Giacomo De Luca, Giorgia Trignani, Alessandro Tomelleri, Marco Matucci-Cerinic and Lorenzo Dagna
The Journal of Rheumatology September 2022, jrheum.220213; DOI: https://doi.org/10.3899/jrheum.220213
Corrado Campochiaro
Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele, Milan; Vita-Salute San Raffaele University, Milan; Department of Rheumatology, University of Florence, Florence, Italy. C. Campochiaro and N. Farina contributed equally as first authors. CC, GDL, and LD received speaking fees from SOBI. The remaining authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. C. Campochiaro, Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele, Via Olgettina 60, 20132, Milan, Italy. Email: campochiaro.corrado@hsr.it.
Nicola Farina
Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele, Milan; Vita-Salute San Raffaele University, Milan; Department of Rheumatology, University of Florence, Florence, Italy. C. Campochiaro and N. Farina contributed equally as first authors. CC, GDL, and LD received speaking fees from SOBI. The remaining authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. C. Campochiaro, Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele, Via Olgettina 60, 20132, Milan, Italy. Email: campochiaro.corrado@hsr.it.
Giacomo De Luca
Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele, Milan; Vita-Salute San Raffaele University, Milan; Department of Rheumatology, University of Florence, Florence, Italy. C. Campochiaro and N. Farina contributed equally as first authors. CC, GDL, and LD received speaking fees from SOBI. The remaining authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. C. Campochiaro, Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele, Via Olgettina 60, 20132, Milan, Italy. Email: campochiaro.corrado@hsr.it.
Giorgia Trignani
Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele, Milan; Vita-Salute San Raffaele University, Milan; Department of Rheumatology, University of Florence, Florence, Italy. C. Campochiaro and N. Farina contributed equally as first authors. CC, GDL, and LD received speaking fees from SOBI. The remaining authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. C. Campochiaro, Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele, Via Olgettina 60, 20132, Milan, Italy. Email: campochiaro.corrado@hsr.it.
Alessandro Tomelleri
Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele, Milan; Vita-Salute San Raffaele University, Milan; Department of Rheumatology, University of Florence, Florence, Italy. C. Campochiaro and N. Farina contributed equally as first authors. CC, GDL, and LD received speaking fees from SOBI. The remaining authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. C. Campochiaro, Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele, Via Olgettina 60, 20132, Milan, Italy. Email: campochiaro.corrado@hsr.it.
Marco Matucci-Cerinic
Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele, Milan; Vita-Salute San Raffaele University, Milan; Department of Rheumatology, University of Florence, Florence, Italy. C. Campochiaro and N. Farina contributed equally as first authors. CC, GDL, and LD received speaking fees from SOBI. The remaining authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. C. Campochiaro, Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele, Via Olgettina 60, 20132, Milan, Italy. Email: campochiaro.corrado@hsr.it.
Lorenzo Dagna
Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele, Milan; Vita-Salute San Raffaele University, Milan; Department of Rheumatology, University of Florence, Florence, Italy. C. Campochiaro and N. Farina contributed equally as first authors. CC, GDL, and LD received speaking fees from SOBI. The remaining authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. C. Campochiaro, Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele, Via Olgettina 60, 20132, Milan, Italy. Email: campochiaro.corrado@hsr.it.
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 3
1 Mar 2024
Anakinra for the Treatment of Antisynthetase Syndrome: A Monocentric Case Series and a Systematic Literature Review
Corrado Campochiaro, Nicola Farina, Giacomo De Luca, Giorgia Trignani, Alessandro Tomelleri, Marco Matucci-Cerinic, Lorenzo Dagna
The Journal of Rheumatology Sep 2022, jrheum.220213; DOI: 10.3899/jrheum.220213
Anakinra for the Treatment of Antisynthetase Syndrome: A Monocentric Case Series and a Systematic Literature Review
Corrado Campochiaro, Nicola Farina, Giacomo De Luca, Giorgia Trignani, Alessandro Tomelleri, Marco Matucci-Cerinic, Lorenzo Dagna
The Journal of Rheumatology Sep 2022, jrheum.220213; DOI: 10.3899/jrheum.220213